EUVIMEDEUVIMED entdecken
Crossref

Glial high-mobility group box 1 translocation promotes post-stroke epileptic seizures

Chao Zhong, Wenqi Wang, Jinghong Li, Zhongxia Li, Xukun Fan, Shuye Ying, Zhehao Yu, Jiaqi Cao, Lin Yang, Yi Wang, Zhong Chen, Yiqi Wang und 1 weitere

Neurochemistry International · 2026-10 · 199 · 106213

DOI: 10.1016/j.neuint.2026.106213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurochemistry International, 2026-10. Verfasst von Chao Zhong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School…. Hauptthemen laut MEDLINE: HMGB1 Protein, Stroke, Neuroglia, Epilepsy. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Zhejiang Chinese Medical University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Post-stroke epilepsy (PSE) is a common type of epilepsy, often refractory to conventional pharmacological interventions. In the present study, we investigate the role of high mobility group box 1 (HMGB1) in PSE and evaluate therapeutic efficacy of the anti-HMGB1 monoclonal antibody therapy. We find that photothrombotic model of ischemic stroke enhanced seizure susceptibility, particularly in cases with extensive cortical lesions. Mechanistically, this vulnerability is driven by the nuclear-to-cytoplasmic translocation of HMGB1. Notably, the translocation rate in glial cells, rather than neurons, positively correlates with seizure severity. Treatment with an anti-HMGB1 monoclonal antibody not only markedly suppressed spontaneous seizures and pentylenetetrazol-induced susceptibility but also rescued cognitive deficits in PSE mice. These neuroprotective effects were mediated by the suppression of glial activation and the inhibition of HMGB1 translocation. Collectively, our findings identify glial HMGB1 translocation as a key driver of PSE and establish anti-HMGB1 therapy as a potent strategy for PSE intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HMGB1 ProteinStrokeNeurogliaEpilepsySeizuresAnimalsMaleMiceMice, Inbred C57BLProtein Transport

Stichwörter der Autor:innen

AstrocytesHigh-mobility group box 1MicrogliaPost-stroke epilepsySeizure

Substanzen

HMGB1 ProteinHMGB1 protein, mouse

Autor:innen und Institutionen

  • Zhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chi…

Förderung

  • Zhejiang Chinese Medical University
  • National Natural Science Foundation of China

Zitieren

APA

Zhong, C., Wang, W., Li, J., Li, Z., Fan, X., Ying, S., Yu, Z., Cao, J., Yang, L., Wang, Y., Chen, Z., Wang, Y., & Fei, F. (2026). Glial high-mobility group box 1 translocation promotes post-stroke epileptic seizures. Neurochemistry International, 199, 106213. https://doi.org/10.1016/j.neuint.2026.106213

Vancouver

Zhong C, Wang W, Li J, Li Z, Fan X, Ying S, et al. Glial high-mobility group box 1 translocation promotes post-stroke epileptic seizures. Neurochemistry International. 2026;199:106213. doi:10.1016/j.neuint.2026.106213

BibTeX
@article{Zhong2026,
  author = {Zhong, Chao and Wang, Wenqi and Li, Jinghong and Li, Zhongxia and Fan, Xukun and Ying, Shuye and Yu, Zhehao and Cao, Jiaqi and Yang, Lin and Wang, Yi and Chen, Zhong and Wang, Yiqi and Fei, Fan},
  title = {Glial high-mobility group box 1 translocation promotes post-stroke epileptic seizures},
  journal = {Neurochemistry International},
  year = {2026},
  volume = {199},
  pages = {106213},
  doi = {10.1016/j.neuint.2026.106213}
}
Kostenlos starten →